Veterinary Medicines

SURRICOXX 400 mg/mL Solution for use in drinking water for chickens, turkeys, ducks, and guinea fowls

Authorised
  • Amprolium hydrochloride
Download as PDF

Product identification

Medicine name:
SURRICOXX 400 MG/ML SOLUTION FOR USE IN DRINKING WATER FOR CHICKENS, TURKEYS, DUCKS, AND GUINEA FOWLS
SURRICOXX 400 mg/mL Solution for use in drinking water for chickens, turkeys, ducks, and guinea fowls
Active substance:
  • Amprolium hydrochloride
Target species:
  • Turkey
  • Guinea fowl
  • Duck
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Amprolium hydrochloride
    452.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Turkey
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Guinea fowl
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Duck
      • Meat and offal
        0
        day
      • Eggs
        0
        day
    • Chicken
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51AX09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Malta
Package description:
  • 100 mL bottle
  • 5 L multidose container
  • 1L bottle

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoires Biove
  • V.M.D.
Responsible authority:
  • Ministry for Food, Agriculture and Fisheries
Authorisation number:
  • VMA 114
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0422/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)